Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia Cells. | Int J Mol Sci | 2023 | 37298237 | PubTator, text mining | PubMed |
| Precise Conformational Control Yielding Highly Potent and Exceptionally Selective BRD4 Degraders with Strong Antitumor Activity. | J Med Chem | 2023 | 37289649 | PubTator, text mining | PubMed |
| RNF112-mediated FOXM1 ubiquitination suppresses the proliferation and invasion of gastric cancer. | JCI Insight | 2023 | 37288663 | PubTator, text mining | PubMed |
| Therapeutic strategies to enhance immune response induced by multiple myeloma cells. | Front Immunol | 2023 | 37275861 | PubTator, text mining | PubMed |
| Targeting CDK9 with selective inhibitors or degraders in tumor therapy: an overview of recent developments. | Cancer Biol Ther | 2023 | 37272701 | PubTator, text mining | PubMed |
| Protein-protein interactions: developing small-molecule inhibitors/stabilizers through covalent strategies. | Trends Pharmacol Sci | 2023 | 37263826 | PubTator, text mining | PubMed |
| PROTACs: A novel strategy for cancer drug discovery and development. | MedComm (2020) | 2023 | 37261210 | PubTator, text mining | PubMed |
| Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4. | Bioorg Med Chem | 2023 | 37257255 | PubTator, text mining | PubMed |
| Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease. | Biomed Pharmacother | 2023 | 37257228 | PubTator, text mining | PubMed |
| Allosteric regulation of the 20S proteasome by the Catalytic Core Regulators (CCRs) family. | Nat Commun | 2023 | 37253751 | PubTator, text mining | PubMed |
| Toward In Silico Design of Protein-Protein Interaction Stabilizers. | ACS Cent Sci | 2023 | 37252366 | PubTator, text mining | PubMed |
| Rational Chemical Design of Molecular Glue Degraders. | ACS Cent Sci | 2023 | 37252349 | PubTator, text mining | PubMed |
| Biological research on the occurrence and development of multiple myeloma and its treatment. | Immun Inflamm Dis | 2023 | 37249283 | PubTator, text mining | PubMed |
| Methyltransferase-independent function of enhancer of zeste homologue 2 maintains tumorigenicity induced by human oncogenic papillomavirus and polyomavirus. | Tumour Virus Res | 2023 | 37244352 | PubTator, text mining | PubMed |
| Synthesis and Preliminary Characterization of Putative Anle138b-Centered PROTACs against α-Synuclein Aggregation. | Pharmaceutics | 2023 | 37242709 | PubTator, text mining | PubMed |
| Recent Advances in Covalent Drug Discovery. | Pharmaceuticals (Basel) | 2023 | 37242447 | PubTator, text mining | PubMed |
| PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies. | Molecules | 2023 | 37241755 | PubTator, text mining | PubMed |
| Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances. | Int J Mol Sci | 2023 | 37240442 | PubTator, text mining | PubMed |
| GPR19 Coordinates Multiple Molecular Aspects of Stress Responses Associated with the Aging Process. | Int J Mol Sci | 2023 | 37239845 | PubTator, text mining | PubMed |
| A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders. | Biomolecules | 2023 | 37238617 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=35